Cited by 543Cancer, Stress, Anesthesia, and Immune ResponsePancreatic and Hepatic Oncology ResearchPancreatic function and diabetes

β2 Adrenergic-Neurotrophin Feedforward Loop Promotes Pancreatic Cancer

Open access
Renz, Bernhard W., Takahashi, Ryota, Tanaka, Takayuki, Macchini, Marina, Hayakawa, Yoku, Dantes, Zahra, Maurer, H. Carlo, Chen, Xiaowei +22 more·2018·Cancer Cell

Abstract

Catecholamines stimulate epithelial proliferation, but the role of sympathetic nerve signaling in pancreatic ductal adenocarcinoma (PDAC) is poorly understood. Catecholamines promoted ADRB2-dependent PDAC development, nerve growth factor (NGF) secretion, and pancreatic nerve density. Pancreatic Ngf overexpression accelerated tumor development in LSL-Kras+/G12D;Pdx1-Cre (KC) mice. ADRB2 blockade together with gemcitabine reduced NGF expression and nerve density, and increased survival of LSL-Kras+/G12D;LSL-Trp53+/R172H;Pdx1-Cre (KPC) mice. Therapy with a Trk inhibitor together with gemcitabine also increased survival of KPC mice. Analysis of PDAC patient cohorts revealed a correlation between brain-derived neurotrophic factor (BDNF) expression, nerve density, and increased survival of patients on nonselective β-blockers. These findings suggest that catecholamines drive a feedforward loop, whereby upregulation of neurotrophins increases sympathetic innervation and local norepinephrine accumulation.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.ccell.2017.11.007

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Renz et al. demonstrated in a cohort of 631 PDAC patients that intake of a non-selective betablocker, such as propranolol, led to improved overall survival compared to patients without betablocker therapy (40 vs 23 months median overall survival).

    “Furthermore, they demonstrated in a cohort of 631 PDAC patients that the intake of a non-selective betablocker, such as propranolol, led to an improved overall survival compared to patients without betablocker therapy (40 vs. 23 months median overall survival) [25].”

    From Pancreatic resection with perioperative drug repurposing of propranolol and etodolac – the phase II randomized controlled PROSPER trial (2025) · cites this paper as [25]

    Split into 2 atoms — 1 confirmed, 1 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.

    Experimental — accuracy not yet measured
  • The tumor-promoting effect of catecholamines is mainly mediated by the β2 adrenergic receptor activating the cAMP-PKA signaling pathway, which enhances tumor angiogenesis and promotes growth of malignant cells.

    “The tumor-promoting effect of catecholamines is mainly mediated by the β2 adrenergic receptor (encoded by ADRB2) activating the cAMP-protein kinase A (PKA) signaling pathway, which is the main mechanism to enhance tumor angiogenesis in the body and promote the growth of malignant cells [(34, 35); Figure 2].”

    From Chronic Stress Promotes Cancer Development (2020) · cites this paper as [35]

    The Results (page unavailable) link ADRB2 and PKA signaling to increased pancreatic cancer cell growth and neurotrophin secretion. The Discussion (page unavailable) describes a feed-forward mechanism involving nerve growth and tumor growth, not angiogenesis. The copy does not establish angiogenesis as the main mechanism or extend this finding to malignant cells generally. (LLM, conf=0.88)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 49

  1. Anders S Pyl PT Huber W 2015 HTSeq—a Python framework to work with high-throughput sequencing data Bioinformatics 31 2 166 169 25260700 PMC4287950
  2. Apte MV Wilson JS 2012 Dangerous liaisons: pancreatic stellate cells and pancreatic cancer cells J Gastroenterol Hepatol 27 Suppl 2 69 74 22320920
  3. Bapat AA Munoz RM Von Hoff DD Han H 2016 Blocking Nerve Growth Factor Signaling Reduces the Neural Invasion Potential of Pancreatic Cancer Cells PLoS ONE 11 e0165586 27792755 PMC5085053
  4. Barron TI Connolly RM Sharp L Bennett K Visvanathan K 2011 Beta blockers and breast cancer mortality: a population-based study Journal of Clinical Oncology 29 2635 2644 21632503
  5. Beg MS Gupta A Sher D Ali S Khan S Gao A Stewart T Ahn C Berry J Mortensen EM 2017 Impact of Concurrent Medication Use on Pancreatic Cancer Survival-SEER-Medicare Analysis Am J Clin Oncol PMC5503814 28079594
  6. Benowitz LI Routtenberg A 1997 GAP-43: an intrinsic determinant of neuronal development and plasticity Trends in Neurosciences 20 84 91 9023877
  7. Ceyhan GO Bergmann F Kadihasanoglu M Altintas B Demir IE Hinz U Müller MW Giese T Büchler MW Giese NA 2009 Pancreatic neuropathy and neuropathic pain–a comprehensive pathomorphological study of 546 cases Gastroenterology 136 177 186.e1 18992743
  8. Ceyhan GO Demir IE Altintas B Rauch U Thiel G Müller MW Giese NA Friess H Schäfer KH 2008 Neural invasion in pancreatic cancer: a mutual tropism between neurons and cancer cells Biochem Biophys Res Commun 374 442 447 18640096
  9. Chruscinski AJ Rohrer DK Schauble E Desai KH Bernstein D Kobilka BK 1999 Targeted disruption of the beta2 adrenergic receptor gene J Biol Chem 274 16694 16700 10358008
  10. Clark KL Loscalzo M Trask PC Zabora J Philip EJ 2010 Psychological distress in patients with pancreatic cancer—an understudied group Psycho-Oncology 19 1313 1320 20119937
  11. Dang C Zhang Y Ma Q Shimahara Y 2006 Expression of nerve growth factor receptors is correlated with progression and prognosis of human pancreatic cancer J Gastroenterol Hepatol 21 850 858 16704535
  12. Demir IE Friess H Ceyhan GO 2015 Neural plasticity in pancreatitis and pancreatic cancer Nat Rev Gastroenterol Hepatol 12 649 659 26460352
  13. Douma S van Laar T Zevenhoven J Meuwissen R 2004 Suppression of anoikis and induction of metastasis by the neurotrophic receptor TrkB Nature 15329723
  14. Gillespie LN 2003 Regulation of axonal growth and guidance by the neurotrophin family of neurotrophic factors Clin Exp Pharmacol Physiol 30 724 733 14516410
  15. Guerra C Schuhmacher AJ Cañamero M Grippo PJ Verdaguer L Pérez-Gallego L Dubus P Sandgren EP Barbacid M 2007 Chronic Pancreatitis Is Essential for Induction of Pancreatic Ductal Adenocarcinoma by K-Ras Oncogenes in Adult Mice Cancer Cell 11 291 302 17349585
  16. Guo K Ma Q Li J Wang Z Shan T Li W Xu Q Xie K 2013 Interaction of the Sympathetic Nerve with Pancreatic Cancer Cells Promotes Perineural Invasion through the Activation of STAT3 Signaling Molecular Cancer Therapeutics 12 264 273 23288783
  17. Hassan S Karpova Y Baiz D Yancey D Pullikuth A Flores A Register T Cline JM D’Agostino R Danial N 2013 Behavioral stress accelerates prostate cancer development in mice J Clin Invest 123 874 886 23348742 PMC3561807
  18. Hayakawa Y Wang TC 2017 Nerves switch on angiogenic metabolism Science 358 305 306 29051365
  19. Hayakawa Y Sakitani K Konishi M Asfaha S Niikura R Tomita H Renz BW Tailor Y Macchini M Middelhoff M 2017 Nerve Growth Factor Promotes Gastric Tumorigenesis through Aberrant Cholinergic Signaling Cancer Cell 31 21 34 27989802 PMC5225031
  20. Hingorani SR Petricoin EF Maitra A Rajapakse V King C Jacobetz MA Ross S Conrads TP Veenstra TD Hitt BA 2003 Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse Cancer Cell 4 437 450 14706336
  21. Hingorani SR Wang L Multani AS Combs C Deramaudt TB Hruban RH Rustgi AK Chang S Tuveson DA 2005 Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice Cancer Cell 7 469 483 15894267
  22. Jansen L Hoffmeister M Arndt V Chang-Claude J Brenner H 2014 Stage-specific associations between beta blocker use and prognosis after colorectal cancer Cancer 120 1178 1186 24415516
  23. Kiberstis PA 2017 Cancer and nerves: A tuf(t) partnership Science 355 144 145 28082581
  24. Kim-Fuchs C Le CP Pimentel MA Shackleford D Ferrari D Angst E Hollande F Sloan EK 2014 Chronic stress accelerates pancreatic cancer growth and invasion: A critical role for beta-adrenergic signaling in the pancreatic microenvironment 1 8 PMC4102665 24650449
  25. Kopp JL von Figura G Mayes E Liu F-F Dubois CL Morris JP Iv Pan FC Akiyama H Wright CVE Jensen K 2012 Identification of Sox9-Dependent Acinar-to-Ductal Reprogramming as the Principal Mechanism for Initiation of Pancreatic Ductal Adenocarcinoma Cancer Cell 22 737 750 23201164 PMC3568632
  26. Lemeshow S Sørensen HT Phillips G Yang EV Antonsen S Riis AH Lesinski GB Jackson R Glaser R 2011 β-Blockers and survival among Danish patients with malignant melanoma: a population-based cohort study Cancer Epidemiol Biomarkers Prev 20 2273 2279 21933972 PMC3652234
  27. Longair MH Baker DA Armstrong JD 2011 Simple Neurite Tracer: open source software for reconstruction, visualization and analysis of neuronal processes Bioinformatics 27 2453 2454 21727141
  28. Madden KS Szpunar MJ Brown EB 2011 β-Adrenergic receptors (β-AR) regulate VEGF and IL-6 production by divergent pathways in high β-AR-expressing breast cancer cell lines Breast Cancer Res Treat 130 747 758 21234673 PMC3126869
  29. Miknyoczki SJ Lang D Huang L Klein-Szanto AJ Dionne CA Ruggeri BA 1999 Neurotrophins and Trk receptors in human pancreatic ductal adenocarcinoma: expression patterns and effects on in vitro invasive behavior Int J Cancer 81 417 427 10209957
  30. Monje M 2017 Settling a Nervous Stomach: The Neural Regulation of Enteric Cancer Cancer Cell 31 1 2 28073000
  31. Myers RB Oelschlager D Srivastava S Grizzle WE 1994 Accumulation of the p53 protein occurs more frequently in metastatic than in localized prostatic adenocarcinomas Prostate 25 243 248 7971515
  32. Partecke LI Speerforck S Käding A Seubert F Kühn S Lorenz E Schwandke S Sendler M Keßler W Trung DN 2016 Chronic stress increases experimental pancreatic cancer growth, reduces survival and can be antagonised by beta-adrenergic receptor blockade Pancreatology 16 1 11 27083074
  33. Peterson SC Eberl M Vagnozzi AN Belkadi A Veniaminova NA Verhaegen ME Bichakjian CK Ward NL Dlugosz AA Wong SY 2015 Basal Cell Carcinoma Preferentially Arises from Stem Cells within Hair Follicle and Mechanosensory Niches Cell Stem Cell 16 400 412 25842978 PMC4387376
  34. Pérez Piñero C Bruzzone A Sarappa MG Castillo LF Lüthy IA 2012 Involvement of α2- and β2-adrenoceptors on breast cancer cell proliferation and tumour growth regulation Br J Pharmacol 166 721 736 22122228 PMC3417500
  35. Rahib L Smith BD Aizenberg R Rosenzweig AB Fleshman JM Matrisian LM 2014 Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United States Cancer Research 74 2913 2921 24840647
  36. Reichert M Takano S Heeg S Bakir B Botta GP Rustgi AK 2013 Isolation, culture and genetic manipulation of mouse pancreatic ductal cells Nat Protoc 8 1354 1365 23787893 PMC4121532
  37. Saloman JL Albers KM Li D Hartman DJ Crawford HC Muha EA Rhim AD Davis BM 2016 Ablation of sensory neurons in a genetic model of pancreatic ductal adenocarcinoma slows initiation and progression of cancer Pnas 201512603 201512606 PMC4801275 26929329
  38. Schuller HM Al-Wadei HAN Ullah MF Plummer HK III 2011 Regulation of pancreatic cancer by neuropsychological stress responses: a novel target for intervention Carcinogenesis 33 bgr251 196 PMC3276326 22072614
  39. Secq V Leca J Bressy C Guillaumond F Skrobuk P Nigri J Lac S Lavaut MN Bui TT Thakur AK 2015 Stromal SLIT2 impacts on pancreatic cancer-associated neural remodeling Cell Death Dis 6 e1592 25590802 PMC4669755
  40. Sinha S Fu YY Grimont A Ketcham M Lafaro KJ Saglimbeni JA Askan G Bailey JM Melchor JP Zhong Y 2017 PanIN neuroendocrine cells promote tumorigenesis via neuronal crosstalk Cancer Research PMC5471615 28386018
  41. Stopczynski RE Normolle D Hartman DJ Ying H Deberry JJ Bielefeldt K Rhim AD Depinho RA Albers KM Davis BM 2014 Neuroplastic changes occur early in the development of pancreatic ductaladenocarcinoma Cancer Research 74 1718 1727 24448244 PMC4036226
  42. Trapnell C Pachter L Salzberg SL 2009 TopHat: discovering splice junctions with RNA-Seq Bioinformatics 25 1105 1111 19289445 PMC2672628
  43. Udumyan R Montgomery S Fang F Almroth H Valdimarsdottir U Ekbom A Smedby KE Fall K 2017 Beta-blocker drug use and survival among patients with pancreatic adenocarcinoma Cancer Research 28473530
  44. Watkins JL Thaker PH Nick AM Ramondetta LM Kumar S Urbauer DL Matsuo K Squires KC Coleman RL Lutgendorf SK 2015 Clinical impact of selective and nonselective beta-blockers on survival in patients with ovarian cancer Cancer 121 3444 3451 26301456 PMC4575637
  45. Weddle DL Tithoff P Williams M Schuller HM 2001 Beta-adrenergic growth regulation of human cancer cell lines derived from pancreatic ductal carcinomas Carcinogenesis 22 473 479 11238189
  46. Zahalka AH Arnal-Estapé A Maryanovich M Nakahara F Cruz CD Finley LWS Frenette PS 2017 Adrenergic nerves activate an angio-metabolic switch in prostate cancer Science 358 321 326 29051371 PMC5783182
  47. Zhang D Ma QY Hu HT Zhang M 2010 β2-adrenergic antagonists suppress pancreatic cancer cell invasion by inhibiting CREB, NFκB and AP-1 Cancer Biol Ther 10 19 29 20424515
  48. Zhao CM Hayakawa Y Kodama Y Muthupalani S Westphalen CB Andersen GT Flatberg A Johannessen H Friedman RA Renz BW 2014 Denervation suppresses gastric tumorigenesis Sci Transl Med 6 250ra115 250ra115 PMC4374618 25143365
  49. Zhu Z Friess H diMola FF Zimmermann A Graber HU Korc M Büchler MW 1999 Nerve growth factor expression correlates with perineural invasion and pain in human pancreatic cancer J Clin Oncol 17 2419 2428 10561305

Cited by

Sorted by citations

Authors
Renz, B. W., Takahashi, R., Tanaka, T., Macchini, M., Hayakawa, Y., Dantes, Z., Maurer, H. C., Chen, X., Jiang, Z., Westphalen, C. B., Ilmer, M., Valenti, G., Mohanta, S. K., Habenicht, A. J. R., Middelhoff, M., Chu, T., Nagar, K., Tailor, Y., Casadei, R., Di Marco, M., Kleespies, A., Friedman, R. A., Remotti, H., Reichert, M., Worthley, D. L., Neumann, J., Werner, J., Iuga, A. C., Olive, K. P., & Wang, T. C.
Affiliations
  • Columbia University Irving Medical Center (US)
  • TUM Klinikum (DE)
  • Ludwig-Maximilians-Universität München (DE)
  • Institut für Prophylaxe und Epidemiologie der Kreislaufkrankheiten (DE)
  • IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola (IT)
Corresponding author
Wang, Timothy C.
Venue
Cancer Cell
Publisher
Elsevier BV
Published
2018-01
Volume
33
Issue
1
Pages
75-90.e7
ISSN
1535-6108 (ISSN-L)
OpenAlex
W2771271491
Cited by
543
References
9
Citations by year
2026: 93 · 2025: 87 · 2024: 70 · 2023: 68 · 2022: 62 · 2021: 66 · 2020: 50 · 2019: 32 · 2018: 13 · 2017: 1
FWCI
21.57
Type
journal article
Language
en
Update notices
erratum (2018-11-12)
Open access
Locations
  • Cancer Cell (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
  • Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) (submittedVersion, cc-by-nc-nd)
  • mediaTUM – the media and publications repository of the Technical University Munich (Technical University Munich) (submittedVersion)
Funders
  • NIH (P30CA013696, S10RR025686, R35CA210088)
  • Cancer Center Flow Core Facility (P30CA013696)
  • Plexxikon Inc.
  • Pancreatic Cancer Action Network - ACCR
  • Lustgarten Foundation
  • German Research Foundation (DFG RE3440/1-1, DFG MO3054/1-1, DFG HA1083/15-4)
  • Uehara Memorial Foundation
  • Japanese Society of Gastroenterology
  • Japan Agency of Medical Research and Development
  • National Pancreas Foundation
  • German Cancer Aid Foundation
  • KKF Program
  • AGA-Actavis Research Award
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Cancer, Stress, Anesthesia, and Immune Response
  • Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
  • Health Sciences › Medicine › Surgery › Pancreatic function and diabetes
Keywords
pancreatic ductal adenocarcinoma, beta2-adrenergic receptor, catecholamines, sympathetic innervation, nerve growth factor, brain-derived neurotrophic factor, norepinephrine, feed-forward loop, KPC mice, gemcitabine, beta-blockers, tumor progression, patient survival
MeSH terms
Gemcitabine, Animals, Carcinoma in Situ, Catecholamines, Deoxycytidine, Mice, Transgenic, Nerve Growth Factors, Pancreatic Neoplasms, Adrenergic Agents, Cell Line, Tumor

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review